Panton–Valentine leukocidin-positive Staphylococcus aureus: a position statement from the International Society of Chemotherapy

Panton–Valentine leukocidin (PVL), a pore-forming cytotoxic secreted toxin, has been associated with severe Staphylococcus aureus pneumonia and prototypical skin lesions. The reported incidence and prevalence of PVL-positive S. aureus (PVLP-SA) varies globally and suffers from a selective reporting...

Full description

Bibliographic Details
Main Authors: Saeed, K., Gould, I., Espositio, S., Ahmad-Saeed, N., Ahmed, S., Alp, E., Bal, A., Bassetti, M., Bonnet, E., Chan, M., Coombs, Geoffrey, Dancer, S., David, M., De Simone, G., Dryden, M., Guardabassi, L., Hanitsch, L., Hijazi, K., Krüger, R., Lee, A., Leistner, R., Pagliano, P., Righi, E., Schneider-Burrus, S., Skov, R., Tattevin, P., Van Wamel, W., Vos, M., Voss, A.
Format: Journal Article
Published: Elsevier Science 2018
Online Access:http://hdl.handle.net/20.500.11937/69497
Description
Summary:Panton–Valentine leukocidin (PVL), a pore-forming cytotoxic secreted toxin, has been associated with severe Staphylococcus aureus pneumonia and prototypical skin lesions. The reported incidence and prevalence of PVL-positive S. aureus (PVLP-SA) varies globally and suffers from a selective reporting bias towards community-associated methicillin-resistant S. aureus (CA-MRSA). Recent studies, however, have identified PVL-positive methicillin-susceptible S. aureus (MSSA) more frequently than previously expected. In this review, a group of experts from four continents affiliated with the International Society of Chemotherapy (ISC) offer a position statement on the important aspects of PVL in S. aureus epidemiology, antimicrobial treatment and decolonisation, and aim to highlight future areas for collaboration and research.